Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum
- Conditions
- Lung CancerTobacco Use Disorder
- Interventions
- Drug: defined green tea catechin extractOther: placebo
- First Posted Date
- 2007-12-14
- Last Posted Date
- 2012-03-09
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 53
- Registration Number
- NCT00573885
- Locations
- 🇨🇦
British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol
- Conditions
- Lung CancerPrecancerous Condition
- First Posted Date
- 2007-12-07
- Last Posted Date
- 2012-03-09
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 30
- Registration Number
- NCT00569712
- Locations
- 🇨🇦
British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia
- Conditions
- Lung CancerPrecancerous Condition
- Interventions
- Dietary Supplement: multi-herbal agent ACAPHADietary Supplement: Sugar Pill
- First Posted Date
- 2007-08-29
- Last Posted Date
- 2012-03-09
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 90
- Registration Number
- NCT00522197
Randomized Anastrozole Exercise Trial
- Conditions
- Musculoskeletal Symptoms
- Interventions
- Other: ExerciseOther: Supportive Care
- First Posted Date
- 2007-08-23
- Last Posted Date
- 2014-08-25
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 72
- Registration Number
- NCT00519883
- Locations
- 🇨🇦
BC Cancer Agency Vancouver Island, Victoria, British Columbia, Canada
🇨🇦BC Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada
Study of Tumour Response to Tirapazamine During Treatment of Cervical Cancer
- Conditions
- Cervix Cancer
- First Posted Date
- 2007-06-28
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 1
- Registration Number
- NCT00493376
- Locations
- 🇨🇦
British Columbia Cancer Agency, Vancouver Centre, Vancouver, British Columbia, Canada
Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer
- Conditions
- Rash
- Interventions
- First Posted Date
- 2007-05-14
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 150
- Registration Number
- NCT00473083
- Locations
- 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦Cross Cancer Institute, Edmonton, Alberta, Canada
🇨🇦BC Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada
A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer
- Conditions
- Adenocarcinoma of the Prostate
- First Posted Date
- 2007-02-01
- Last Posted Date
- 2010-08-05
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 39
- Registration Number
- NCT00430235
- Locations
- 🇨🇦
BC Cancer Agency - Vancouver Centre, Vancouver, British Columbia, Canada
Intensity Modulated Versus Interstitial - Radiation Therapy
- Conditions
- Prostate Cancer
- Interventions
- Procedure: Intensity Modulated External Beam Radiation Therapy
- First Posted Date
- 2006-12-05
- Last Posted Date
- 2018-07-13
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 50
- Registration Number
- NCT00407875
- Locations
- 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada
Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy
- Conditions
- Hormone Refractory Prostate Cancer
- First Posted Date
- 2006-12-04
- Last Posted Date
- 2010-11-05
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 73
- Registration Number
- NCT00407251
- Locations
- 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
🇨🇦Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦BC Cancer Agency - Vancouver Centre, Vancouver, British Columbia, Canada
Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial
- Conditions
- Advanced Colorectal Cancer
- First Posted Date
- 2006-10-12
- Last Posted Date
- 2010-11-25
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 43
- Registration Number
- NCT00386828
- Locations
- 🇨🇦
CancerCare Manitoba, Winnipeg, Manitoba, Canada
🇨🇦Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦BC Cancer Agency - Vancouver Centre, Vancouver, British Columbia, Canada